nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2D6—Alzheimer's disease	0.287	1	CbGaD
Metoprolol—SLC22A2—Memantine—Alzheimer's disease	0.219	0.461	CbGbCtD
Metoprolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0792	0.167	CbGbCtD
Metoprolol—CYP2C19—Memantine—Alzheimer's disease	0.0722	0.152	CbGbCtD
Metoprolol—CYP2D6—Donepezil—Alzheimer's disease	0.0633	0.133	CbGbCtD
Metoprolol—CYP2D6—Galantamine—Alzheimer's disease	0.0408	0.086	CbGbCtD
Metoprolol—Chlorphenesin—BCHE—Alzheimer's disease	0.000616	0.216	CrCbGaD
Metoprolol—Dysgeusia—Galantamine—Alzheimer's disease	0.000438	0.00221	CcSEcCtD
Metoprolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000435	0.00219	CcSEcCtD
Metoprolol—Nervousness—Galantamine—Alzheimer's disease	0.000435	0.00219	CcSEcCtD
Metoprolol—Jaundice—Donepezil—Alzheimer's disease	0.000433	0.00218	CcSEcCtD
Metoprolol—Conjunctivitis—Donepezil—Alzheimer's disease	0.000432	0.00218	CcSEcCtD
Metoprolol—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000431	0.00217	CcSEcCtD
Metoprolol—Sweating increased—Rivastigmine—Alzheimer's disease	0.000431	0.00217	CcSEcCtD
Metoprolol—Muscle spasms—Galantamine—Alzheimer's disease	0.00043	0.00217	CcSEcCtD
Metoprolol—Sweating—Donepezil—Alzheimer's disease	0.000426	0.00215	CcSEcCtD
Metoprolol—Vision blurred—Galantamine—Alzheimer's disease	0.000422	0.00213	CcSEcCtD
Metoprolol—Erectile dysfunction—Memantine—Alzheimer's disease	0.000416	0.0021	CcSEcCtD
Metoprolol—Weight increased—Memantine—Alzheimer's disease	0.000412	0.00208	CcSEcCtD
Metoprolol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000407	0.00205	CcSEcCtD
Metoprolol—Bradycardia—Donepezil—Alzheimer's disease	0.000406	0.00205	CcSEcCtD
Metoprolol—Pneumonia—Memantine—Alzheimer's disease	0.000406	0.00204	CcSEcCtD
Metoprolol—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000404	0.00204	CcSEcCtD
Metoprolol—Weight increased—Rivastigmine—Alzheimer's disease	0.000403	0.00203	CcSEcCtD
Metoprolol—Vertigo—Galantamine—Alzheimer's disease	0.000402	0.00203	CcSEcCtD
Metoprolol—Depression—Memantine—Alzheimer's disease	0.000402	0.00203	CcSEcCtD
Metoprolol—Syncope—Galantamine—Alzheimer's disease	0.000402	0.00202	CcSEcCtD
Metoprolol—Rhinitis—Donepezil—Alzheimer's disease	0.0004	0.00202	CcSEcCtD
Metoprolol—Hepatitis—Donepezil—Alzheimer's disease	0.000399	0.00201	CcSEcCtD
Metoprolol—Pneumonia—Rivastigmine—Alzheimer's disease	0.000397	0.002	CcSEcCtD
Metoprolol—Hallucination—Donepezil—Alzheimer's disease	0.000397	0.002	CcSEcCtD
Metoprolol—Palpitations—Galantamine—Alzheimer's disease	0.000396	0.002	CcSEcCtD
Metoprolol—Loss of consciousness—Galantamine—Alzheimer's disease	0.000394	0.00198	CcSEcCtD
Metoprolol—Depression—Rivastigmine—Alzheimer's disease	0.000393	0.00198	CcSEcCtD
Metoprolol—Oedema peripheral—Donepezil—Alzheimer's disease	0.000393	0.00198	CcSEcCtD
Metoprolol—Conjunctivitis—Memantine—Alzheimer's disease	0.000392	0.00198	CcSEcCtD
Metoprolol—Hypertension—Galantamine—Alzheimer's disease	0.000387	0.00195	CcSEcCtD
Metoprolol—Visual impairment—Donepezil—Alzheimer's disease	0.000384	0.00194	CcSEcCtD
Metoprolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000383	0.00193	CcSEcCtD
Metoprolol—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000381	0.00192	CcSEcCtD
Metoprolol—Chest pain—Galantamine—Alzheimer's disease	0.000381	0.00192	CcSEcCtD
Metoprolol—Arthralgia—Galantamine—Alzheimer's disease	0.000381	0.00192	CcSEcCtD
Metoprolol—Anxiety—Galantamine—Alzheimer's disease	0.00038	0.00192	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000379	0.00191	CcSEcCtD
Metoprolol—Sweating—Rivastigmine—Alzheimer's disease	0.000378	0.00191	CcSEcCtD
Metoprolol—Agranulocytosis—Memantine—Alzheimer's disease	0.000376	0.0019	CcSEcCtD
Metoprolol—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000373	0.00188	CcSEcCtD
Metoprolol—Dry mouth—Galantamine—Alzheimer's disease	0.000373	0.00188	CcSEcCtD
Metoprolol—Tinnitus—Donepezil—Alzheimer's disease	0.000372	0.00187	CcSEcCtD
Metoprolol—Confusional state—Galantamine—Alzheimer's disease	0.000368	0.00186	CcSEcCtD
Metoprolol—Bradycardia—Memantine—Alzheimer's disease	0.000368	0.00186	CcSEcCtD
Metoprolol—Rhinitis—Memantine—Alzheimer's disease	0.000363	0.00183	CcSEcCtD
Metoprolol—Hepatitis—Memantine—Alzheimer's disease	0.000362	0.00183	CcSEcCtD
Metoprolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00036	0.00182	CcSEcCtD
Metoprolol—Hallucination—Memantine—Alzheimer's disease	0.00036	0.00182	CcSEcCtD
Metoprolol—Shock—Galantamine—Alzheimer's disease	0.00036	0.00181	CcSEcCtD
Metoprolol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000358	0.00181	CcSEcCtD
Metoprolol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000358	0.0018	CcSEcCtD
Metoprolol—Tachycardia—Galantamine—Alzheimer's disease	0.000357	0.0018	CcSEcCtD
Metoprolol—Oedema peripheral—Memantine—Alzheimer's disease	0.000357	0.0018	CcSEcCtD
Metoprolol—Arrhythmia—Donepezil—Alzheimer's disease	0.000356	0.0018	CcSEcCtD
Metoprolol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000356	0.00179	CcSEcCtD
Metoprolol—Rhinitis—Rivastigmine—Alzheimer's disease	0.000355	0.00179	CcSEcCtD
Metoprolol—Skin disorder—Galantamine—Alzheimer's disease	0.000355	0.00179	CcSEcCtD
Metoprolol—Hepatitis—Rivastigmine—Alzheimer's disease	0.000354	0.00179	CcSEcCtD
Metoprolol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000353	0.00178	CcSEcCtD
Metoprolol—Hallucination—Rivastigmine—Alzheimer's disease	0.000352	0.00178	CcSEcCtD
Metoprolol—Alopecia—Donepezil—Alzheimer's disease	0.000352	0.00178	CcSEcCtD
Metoprolol—Mental disorder—Donepezil—Alzheimer's disease	0.000349	0.00176	CcSEcCtD
Metoprolol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000349	0.00176	CcSEcCtD
Metoprolol—Visual impairment—Memantine—Alzheimer's disease	0.000349	0.00176	CcSEcCtD
Metoprolol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000348	0.00175	CcSEcCtD
Metoprolol—Flatulence—Donepezil—Alzheimer's disease	0.000342	0.00172	CcSEcCtD
Metoprolol—Hypotension—Galantamine—Alzheimer's disease	0.000341	0.00172	CcSEcCtD
Metoprolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000341	0.00172	CcSEcCtD
Metoprolol—Betaxolol—CYP2D6—Alzheimer's disease	0.000341	0.12	CrCbGaD
Metoprolol—Tension—Donepezil—Alzheimer's disease	0.000341	0.00172	CcSEcCtD
Metoprolol—Dysgeusia—Donepezil—Alzheimer's disease	0.00034	0.00171	CcSEcCtD
Metoprolol—Eye disorder—Memantine—Alzheimer's disease	0.000338	0.00171	CcSEcCtD
Metoprolol—Tinnitus—Memantine—Alzheimer's disease	0.000337	0.0017	CcSEcCtD
Metoprolol—Nervousness—Donepezil—Alzheimer's disease	0.000337	0.0017	CcSEcCtD
Metoprolol—Cardiac disorder—Memantine—Alzheimer's disease	0.000336	0.00169	CcSEcCtD
Metoprolol—Muscle spasms—Donepezil—Alzheimer's disease	0.000334	0.00168	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000333	0.00168	CcSEcCtD
Metoprolol—Eye disorder—Rivastigmine—Alzheimer's disease	0.000331	0.00167	CcSEcCtD
Metoprolol—Insomnia—Galantamine—Alzheimer's disease	0.000331	0.00167	CcSEcCtD
Metoprolol—Tinnitus—Rivastigmine—Alzheimer's disease	0.00033	0.00166	CcSEcCtD
Metoprolol—Bisoprolol—CYP2D6—Alzheimer's disease	0.000329	0.116	CrCbGaD
Metoprolol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000329	0.00166	CcSEcCtD
Metoprolol—Angiopathy—Memantine—Alzheimer's disease	0.000328	0.00166	CcSEcCtD
Metoprolol—Paraesthesia—Galantamine—Alzheimer's disease	0.000328	0.00165	CcSEcCtD
Metoprolol—Vision blurred—Donepezil—Alzheimer's disease	0.000327	0.00165	CcSEcCtD
Metoprolol—Immune system disorder—Memantine—Alzheimer's disease	0.000327	0.00165	CcSEcCtD
Metoprolol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000326	0.00164	CcSEcCtD
Metoprolol—Somnolence—Galantamine—Alzheimer's disease	0.000325	0.00164	CcSEcCtD
Metoprolol—Arrhythmia—Memantine—Alzheimer's disease	0.000323	0.00163	CcSEcCtD
Metoprolol—Dyspepsia—Galantamine—Alzheimer's disease	0.000322	0.00162	CcSEcCtD
Metoprolol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000321	0.00162	CcSEcCtD
Metoprolol—Alopecia—Memantine—Alzheimer's disease	0.00032	0.00161	CcSEcCtD
Metoprolol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000319	0.00161	CcSEcCtD
Metoprolol—Mental disorder—Memantine—Alzheimer's disease	0.000317	0.0016	CcSEcCtD
Metoprolol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000316	0.00159	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000315	0.00159	CcSEcCtD
Metoprolol—Fatigue—Galantamine—Alzheimer's disease	0.000315	0.00159	CcSEcCtD
Metoprolol—Alopecia—Rivastigmine—Alzheimer's disease	0.000313	0.00158	CcSEcCtD
Metoprolol—Constipation—Galantamine—Alzheimer's disease	0.000312	0.00158	CcSEcCtD
Metoprolol—Acebutolol—CYP2D6—Alzheimer's disease	0.000312	0.109	CrCbGaD
Metoprolol—Vertigo—Donepezil—Alzheimer's disease	0.000312	0.00157	CcSEcCtD
Metoprolol—Syncope—Donepezil—Alzheimer's disease	0.000311	0.00157	CcSEcCtD
Metoprolol—Flatulence—Memantine—Alzheimer's disease	0.00031	0.00157	CcSEcCtD
Metoprolol—Mental disorder—Rivastigmine—Alzheimer's disease	0.00031	0.00156	CcSEcCtD
Metoprolol—Oxprenolol—CYP2D6—Alzheimer's disease	0.00031	0.109	CrCbGaD
Metoprolol—Tension—Memantine—Alzheimer's disease	0.000309	0.00156	CcSEcCtD
Metoprolol—Dysgeusia—Memantine—Alzheimer's disease	0.000309	0.00156	CcSEcCtD
Metoprolol—Nervousness—Memantine—Alzheimer's disease	0.000306	0.00154	CcSEcCtD
Metoprolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000305	0.00154	CcSEcCtD
Metoprolol—Flatulence—Rivastigmine—Alzheimer's disease	0.000304	0.00153	CcSEcCtD
Metoprolol—Tension—Rivastigmine—Alzheimer's disease	0.000302	0.00153	CcSEcCtD
Metoprolol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000302	0.00152	CcSEcCtD
Metoprolol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000301	0.00152	CcSEcCtD
Metoprolol—Hypertension—Donepezil—Alzheimer's disease	0.0003	0.00151	CcSEcCtD
Metoprolol—Nervousness—Rivastigmine—Alzheimer's disease	0.000299	0.00151	CcSEcCtD
Metoprolol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000299	0.00151	CcSEcCtD
Metoprolol—Vision blurred—Memantine—Alzheimer's disease	0.000297	0.0015	CcSEcCtD
Metoprolol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000296	0.00149	CcSEcCtD
Metoprolol—Chest pain—Donepezil—Alzheimer's disease	0.000295	0.00149	CcSEcCtD
Metoprolol—Arthralgia—Donepezil—Alzheimer's disease	0.000295	0.00149	CcSEcCtD
Metoprolol—Anxiety—Donepezil—Alzheimer's disease	0.000294	0.00148	CcSEcCtD
Metoprolol—Vision blurred—Rivastigmine—Alzheimer's disease	0.00029	0.00146	CcSEcCtD
Metoprolol—Dry mouth—Donepezil—Alzheimer's disease	0.000289	0.00146	CcSEcCtD
Metoprolol—Abdominal pain—Galantamine—Alzheimer's disease	0.000289	0.00146	CcSEcCtD
Metoprolol—Body temperature increased—Galantamine—Alzheimer's disease	0.000289	0.00146	CcSEcCtD
Metoprolol—Confusional state—Donepezil—Alzheimer's disease	0.000286	0.00144	CcSEcCtD
Metoprolol—Chlorphenesin—PTGS2—Alzheimer's disease	0.000284	0.0995	CrCbGaD
Metoprolol—Oedema—Donepezil—Alzheimer's disease	0.000283	0.00143	CcSEcCtD
Metoprolol—Alprenolol—CYP2D6—Alzheimer's disease	0.000283	0.0993	CrCbGaD
Metoprolol—Vertigo—Memantine—Alzheimer's disease	0.000283	0.00143	CcSEcCtD
Metoprolol—Syncope—Memantine—Alzheimer's disease	0.000283	0.00142	CcSEcCtD
Metoprolol—Leukopenia—Memantine—Alzheimer's disease	0.000282	0.00142	CcSEcCtD
Metoprolol—Shock—Donepezil—Alzheimer's disease	0.000279	0.0014	CcSEcCtD
Metoprolol—Palpitations—Memantine—Alzheimer's disease	0.000278	0.0014	CcSEcCtD
Metoprolol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000278	0.0014	CcSEcCtD
Metoprolol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000277	0.0014	CcSEcCtD
Metoprolol—Vertigo—Rivastigmine—Alzheimer's disease	0.000277	0.0014	CcSEcCtD
Metoprolol—Loss of consciousness—Memantine—Alzheimer's disease	0.000277	0.0014	CcSEcCtD
Metoprolol—Syncope—Rivastigmine—Alzheimer's disease	0.000276	0.00139	CcSEcCtD
Metoprolol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000274	0.00138	CcSEcCtD
Metoprolol—Palpitations—Rivastigmine—Alzheimer's disease	0.000272	0.00137	CcSEcCtD
Metoprolol—Hypertension—Memantine—Alzheimer's disease	0.000272	0.00137	CcSEcCtD
Metoprolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000271	0.00137	CcSEcCtD
Metoprolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000269	0.00136	CcSEcCtD
Metoprolol—Arthralgia—Memantine—Alzheimer's disease	0.000268	0.00135	CcSEcCtD
Metoprolol—Chest pain—Memantine—Alzheimer's disease	0.000268	0.00135	CcSEcCtD
Metoprolol—Anxiety—Memantine—Alzheimer's disease	0.000267	0.00135	CcSEcCtD
Metoprolol—Hypertension—Rivastigmine—Alzheimer's disease	0.000266	0.00134	CcSEcCtD
Metoprolol—Hypotension—Donepezil—Alzheimer's disease	0.000265	0.00133	CcSEcCtD
Metoprolol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Metoprolol—Chest pain—Rivastigmine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Metoprolol—Dry mouth—Memantine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Metoprolol—Asthenia—Galantamine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Metoprolol—Anxiety—Rivastigmine—Alzheimer's disease	0.000262	0.00132	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000261	0.00131	CcSEcCtD
Metoprolol—Confusional state—Memantine—Alzheimer's disease	0.000259	0.00131	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000258	0.0013	CcSEcCtD
Metoprolol—Oedema—Memantine—Alzheimer's disease	0.000257	0.0013	CcSEcCtD
Metoprolol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000257	0.00129	CcSEcCtD
Metoprolol—Insomnia—Donepezil—Alzheimer's disease	0.000256	0.00129	CcSEcCtD
Metoprolol—Paraesthesia—Donepezil—Alzheimer's disease	0.000254	0.00128	CcSEcCtD
Metoprolol—Confusional state—Rivastigmine—Alzheimer's disease	0.000254	0.00128	CcSEcCtD
Metoprolol—Shock—Memantine—Alzheimer's disease	0.000253	0.00128	CcSEcCtD
Metoprolol—Dyspnoea—Donepezil—Alzheimer's disease	0.000252	0.00127	CcSEcCtD
Metoprolol—Nervous system disorder—Memantine—Alzheimer's disease	0.000252	0.00127	CcSEcCtD
Metoprolol—Somnolence—Donepezil—Alzheimer's disease	0.000252	0.00127	CcSEcCtD
Metoprolol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000252	0.00127	CcSEcCtD
Metoprolol—Oedema—Rivastigmine—Alzheimer's disease	0.000252	0.00127	CcSEcCtD
Metoprolol—Tachycardia—Memantine—Alzheimer's disease	0.000251	0.00127	CcSEcCtD
Metoprolol—Diarrhoea—Galantamine—Alzheimer's disease	0.00025	0.00126	CcSEcCtD
Metoprolol—Skin disorder—Memantine—Alzheimer's disease	0.00025	0.00126	CcSEcCtD
Metoprolol—Dyspepsia—Donepezil—Alzheimer's disease	0.000249	0.00126	CcSEcCtD
Metoprolol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000249	0.00125	CcSEcCtD
Metoprolol—Shock—Rivastigmine—Alzheimer's disease	0.000247	0.00125	CcSEcCtD
Metoprolol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000247	0.00124	CcSEcCtD
Metoprolol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000246	0.00124	CcSEcCtD
Metoprolol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000246	0.00124	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000244	0.00123	CcSEcCtD
Metoprolol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000244	0.00123	CcSEcCtD
Metoprolol—Fatigue—Donepezil—Alzheimer's disease	0.000244	0.00123	CcSEcCtD
Metoprolol—Pindolol—CYP2D6—Alzheimer's disease	0.000244	0.0854	CrCbGaD
Metoprolol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000243	0.00123	CcSEcCtD
Metoprolol—Constipation—Donepezil—Alzheimer's disease	0.000242	0.00122	CcSEcCtD
Metoprolol—Pain—Donepezil—Alzheimer's disease	0.000242	0.00122	CcSEcCtD
Metoprolol—Dizziness—Galantamine—Alzheimer's disease	0.000242	0.00122	CcSEcCtD
Metoprolol—Hypotension—Memantine—Alzheimer's disease	0.00024	0.00121	CcSEcCtD
Metoprolol—Hypotension—Rivastigmine—Alzheimer's disease	0.000235	0.00119	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000234	0.00118	CcSEcCtD
Metoprolol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000233	0.00118	CcSEcCtD
Metoprolol—Insomnia—Memantine—Alzheimer's disease	0.000233	0.00117	CcSEcCtD
Metoprolol—Vomiting—Galantamine—Alzheimer's disease	0.000232	0.00117	CcSEcCtD
Metoprolol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000232	0.00117	CcSEcCtD
Metoprolol—Paraesthesia—Memantine—Alzheimer's disease	0.000231	0.00116	CcSEcCtD
Metoprolol—Rash—Galantamine—Alzheimer's disease	0.00023	0.00116	CcSEcCtD
Metoprolol—Dermatitis—Galantamine—Alzheimer's disease	0.00023	0.00116	CcSEcCtD
Metoprolol—Dyspnoea—Memantine—Alzheimer's disease	0.000229	0.00116	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000229	0.00116	CcSEcCtD
Metoprolol—Headache—Galantamine—Alzheimer's disease	0.000229	0.00115	CcSEcCtD
Metoprolol—Somnolence—Memantine—Alzheimer's disease	0.000229	0.00115	CcSEcCtD
Metoprolol—Insomnia—Rivastigmine—Alzheimer's disease	0.000228	0.00115	CcSEcCtD
Metoprolol—Dyspepsia—Memantine—Alzheimer's disease	0.000226	0.00114	CcSEcCtD
Metoprolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000226	0.00114	CcSEcCtD
Metoprolol—Urticaria—Donepezil—Alzheimer's disease	0.000225	0.00113	CcSEcCtD
Metoprolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000224	0.00113	CcSEcCtD
Metoprolol—Abdominal pain—Donepezil—Alzheimer's disease	0.000224	0.00113	CcSEcCtD
Metoprolol—Body temperature increased—Donepezil—Alzheimer's disease	0.000224	0.00113	CcSEcCtD
Metoprolol—Somnolence—Rivastigmine—Alzheimer's disease	0.000224	0.00113	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000222	0.00112	CcSEcCtD
Metoprolol—Fatigue—Memantine—Alzheimer's disease	0.000222	0.00112	CcSEcCtD
Metoprolol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000221	0.00112	CcSEcCtD
Metoprolol—Pain—Memantine—Alzheimer's disease	0.00022	0.00111	CcSEcCtD
Metoprolol—Constipation—Memantine—Alzheimer's disease	0.00022	0.00111	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000217	0.0011	CcSEcCtD
Metoprolol—Nausea—Galantamine—Alzheimer's disease	0.000217	0.00109	CcSEcCtD
Metoprolol—Fatigue—Rivastigmine—Alzheimer's disease	0.000217	0.00109	CcSEcCtD
Metoprolol—Pain—Rivastigmine—Alzheimer's disease	0.000215	0.00108	CcSEcCtD
Metoprolol—Constipation—Rivastigmine—Alzheimer's disease	0.000215	0.00108	CcSEcCtD
Metoprolol—Feeling abnormal—Memantine—Alzheimer's disease	0.000212	0.00107	CcSEcCtD
Metoprolol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00021	0.00106	CcSEcCtD
Metoprolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000209	0.00105	CcSEcCtD
Metoprolol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000207	0.00105	CcSEcCtD
Metoprolol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000206	0.00104	CcSEcCtD
Metoprolol—Urticaria—Memantine—Alzheimer's disease	0.000204	0.00103	CcSEcCtD
Metoprolol—Body temperature increased—Memantine—Alzheimer's disease	0.000203	0.00103	CcSEcCtD
Metoprolol—Abdominal pain—Memantine—Alzheimer's disease	0.000203	0.00103	CcSEcCtD
Metoprolol—Asthenia—Donepezil—Alzheimer's disease	0.000203	0.00102	CcSEcCtD
Metoprolol—Pruritus—Donepezil—Alzheimer's disease	0.0002	0.00101	CcSEcCtD
Metoprolol—Urticaria—Rivastigmine—Alzheimer's disease	0.0002	0.00101	CcSEcCtD
Metoprolol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000199	0.001	CcSEcCtD
Metoprolol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000199	0.001	CcSEcCtD
Metoprolol—Diarrhoea—Donepezil—Alzheimer's disease	0.000194	0.000977	CcSEcCtD
Metoprolol—Hypersensitivity—Memantine—Alzheimer's disease	0.000189	0.000955	CcSEcCtD
Metoprolol—Dizziness—Donepezil—Alzheimer's disease	0.000187	0.000944	CcSEcCtD
Metoprolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000185	0.000935	CcSEcCtD
Metoprolol—Asthenia—Memantine—Alzheimer's disease	0.000184	0.00093	CcSEcCtD
Metoprolol—Pruritus—Memantine—Alzheimer's disease	0.000182	0.000917	CcSEcCtD
Metoprolol—Asthenia—Rivastigmine—Alzheimer's disease	0.00018	0.00091	CcSEcCtD
Metoprolol—Vomiting—Donepezil—Alzheimer's disease	0.00018	0.000908	CcSEcCtD
Metoprolol—Rash—Donepezil—Alzheimer's disease	0.000179	0.0009	CcSEcCtD
Metoprolol—Dermatitis—Donepezil—Alzheimer's disease	0.000178	0.0009	CcSEcCtD
Metoprolol—Pruritus—Rivastigmine—Alzheimer's disease	0.000178	0.000897	CcSEcCtD
Metoprolol—Headache—Donepezil—Alzheimer's disease	0.000177	0.000895	CcSEcCtD
Metoprolol—Diarrhoea—Memantine—Alzheimer's disease	0.000176	0.000887	CcSEcCtD
Metoprolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000172	0.000868	CcSEcCtD
Metoprolol—Dizziness—Memantine—Alzheimer's disease	0.00017	0.000857	CcSEcCtD
Metoprolol—Nausea—Donepezil—Alzheimer's disease	0.000168	0.000848	CcSEcCtD
Metoprolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000166	0.000839	CcSEcCtD
Metoprolol—Vomiting—Memantine—Alzheimer's disease	0.000163	0.000824	CcSEcCtD
Metoprolol—Rash—Memantine—Alzheimer's disease	0.000162	0.000818	CcSEcCtD
Metoprolol—Dermatitis—Memantine—Alzheimer's disease	0.000162	0.000817	CcSEcCtD
Metoprolol—Headache—Memantine—Alzheimer's disease	0.000161	0.000812	CcSEcCtD
Metoprolol—Vomiting—Rivastigmine—Alzheimer's disease	0.00016	0.000807	CcSEcCtD
Metoprolol—Rash—Rivastigmine—Alzheimer's disease	0.000159	0.0008	CcSEcCtD
Metoprolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000158	0.000799	CcSEcCtD
Metoprolol—Headache—Rivastigmine—Alzheimer's disease	0.000158	0.000795	CcSEcCtD
Metoprolol—Nausea—Memantine—Alzheimer's disease	0.000153	0.00077	CcSEcCtD
Metoprolol—Nausea—Rivastigmine—Alzheimer's disease	0.000149	0.000753	CcSEcCtD
Metoprolol—Propranolol—CYP2D6—Alzheimer's disease	0.000133	0.0466	CrCbGaD
Metoprolol—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	2.07e-05	0.000558	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.05e-05	0.000552	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	2.04e-05	0.000552	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	2.04e-05	0.000551	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	2.04e-05	0.00055	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	2.01e-05	0.000544	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.01e-05	0.000542	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—A2M—Alzheimer's disease	2e-05	0.000539	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	1.99e-05	0.000538	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	1.99e-05	0.000537	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	1.99e-05	0.000537	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.98e-05	0.000534	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.97e-05	0.000531	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	1.95e-05	0.000525	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	1.95e-05	0.000525	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.95e-05	0.000525	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.93e-05	0.00052	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.93e-05	0.000519	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.9e-05	0.000513	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ND1—Alzheimer's disease	1.9e-05	0.000512	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.85e-05	0.0005	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.83e-05	0.000494	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.79e-05	0.000483	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.75e-05	0.000473	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.74e-05	0.000469	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ACHE—Alzheimer's disease	1.74e-05	0.000469	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.73e-05	0.000467	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	1.72e-05	0.000463	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.72e-05	0.000463	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.7e-05	0.000459	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.7e-05	0.000458	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.69e-05	0.000457	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.66e-05	0.000449	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.64e-05	0.000442	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	1.63e-05	0.000439	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ENO1—Alzheimer's disease	1.63e-05	0.000439	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.6e-05	0.000433	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.6e-05	0.000433	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	1.6e-05	0.000431	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.57e-05	0.000424	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.57e-05	0.000423	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.56e-05	0.000422	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.56e-05	0.000422	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.55e-05	0.000419	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.54e-05	0.000415	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.53e-05	0.000413	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.52e-05	0.00041	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—BCHE—Alzheimer's disease	1.51e-05	0.000408	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.51e-05	0.000407	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.5e-05	0.000405	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.49e-05	0.000402	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.48e-05	0.000398	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.46e-05	0.000393	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.46e-05	0.000393	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.44e-05	0.000389	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.43e-05	0.000386	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	1.43e-05	0.000385	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.42e-05	0.000384	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.42e-05	0.000384	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.41e-05	0.000379	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.4e-05	0.000378	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.4e-05	0.000378	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.39e-05	0.000376	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.38e-05	0.000374	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	1.38e-05	0.000373	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.38e-05	0.000371	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.37e-05	0.00037	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.36e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.36e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.36e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.36e-05	0.000368	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.36e-05	0.000367	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.35e-05	0.000365	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.33e-05	0.00036	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.33e-05	0.00036	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.33e-05	0.00036	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.33e-05	0.000359	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.33e-05	0.000359	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.32e-05	0.000357	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.32e-05	0.000357	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.3e-05	0.000351	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.28e-05	0.000345	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.25e-05	0.000339	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.25e-05	0.000338	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.25e-05	0.000338	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.25e-05	0.000337	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.24e-05	0.000334	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.23e-05	0.000331	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.22e-05	0.00033	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.22e-05	0.00033	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.2e-05	0.000324	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	1.19e-05	0.000322	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	1.19e-05	0.00032	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.17e-05	0.000317	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.17e-05	0.000316	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.16e-05	0.000314	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	0.000312	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.15e-05	0.000311	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.15e-05	0.000311	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.15e-05	0.000309	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.14e-05	0.000309	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.14e-05	0.000309	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.14e-05	0.000307	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.14e-05	0.000307	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.13e-05	0.000306	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.13e-05	0.000305	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.12e-05	0.000302	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.12e-05	0.000302	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.11e-05	0.0003	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.11e-05	0.000298	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—A2M—Alzheimer's disease	1.09e-05	0.000294	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.09e-05	0.000294	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—LPL—Alzheimer's disease	1.09e-05	0.000293	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.08e-05	0.000292	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.06e-05	0.000287	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.06e-05	0.000285	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.03e-05	0.000278	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.03e-05	0.000277	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.01e-05	0.000272	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.97e-06	0.000269	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	9.95e-06	0.000269	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	9.78e-06	0.000264	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	9.74e-06	0.000263	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.72e-06	0.000262	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	9.61e-06	0.000259	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	9.54e-06	0.000257	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ACHE—Alzheimer's disease	9.49e-06	0.000256	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	9.46e-06	0.000255	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INPP5D—Alzheimer's disease	9.38e-06	0.000253	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	9.34e-06	0.000252	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	9.28e-06	0.00025	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	9.25e-06	0.00025	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	9.21e-06	0.000248	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CALM1—Alzheimer's disease	9.14e-06	0.000246	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ENO1—Alzheimer's disease	9.11e-06	0.000246	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	9.11e-06	0.000246	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—Alzheimer's disease	9.1e-06	0.000246	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	9.08e-06	0.000245	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	9.04e-06	0.000244	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAV1—Alzheimer's disease	9.02e-06	0.000243	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.94e-06	0.000241	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.93e-06	0.000241	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ENO1—Alzheimer's disease	8.89e-06	0.00024	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS1—Alzheimer's disease	8.89e-06	0.00024	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	8.84e-06	0.000239	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.84e-06	0.000239	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	8.79e-06	0.000237	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	8.72e-06	0.000235	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	8.6e-06	0.000232	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	8.6e-06	0.000232	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—BCHE—Alzheimer's disease	8.47e-06	0.000229	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	8.42e-06	0.000227	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	8.38e-06	0.000226	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	8.38e-06	0.000226	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—BCHE—Alzheimer's disease	8.27e-06	0.000223	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	8.03e-06	0.000217	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	8e-06	0.000216	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	8e-06	0.000216	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.99e-06	0.000216	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—Alzheimer's disease	7.93e-06	0.000214	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	7.93e-06	0.000214	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	7.85e-06	0.000212	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.84e-06	0.000212	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	7.82e-06	0.000211	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	7.82e-06	0.000211	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLCB1—Alzheimer's disease	7.8e-06	0.00021	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.79e-06	0.00021	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INS—Alzheimer's disease	7.78e-06	0.00021	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	7.75e-06	0.000209	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.75e-06	0.000209	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.64e-06	0.000206	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCA1—Alzheimer's disease	7.56e-06	0.000204	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	7.54e-06	0.000204	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	7.47e-06	0.000202	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.38e-06	0.000199	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	7.38e-06	0.000199	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.35e-06	0.000198	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.22e-06	0.000195	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.12e-06	0.000192	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	6.93e-06	0.000187	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	6.87e-06	0.000185	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	6.83e-06	0.000184	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—Alzheimer's disease	6.82e-06	0.000184	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	6.78e-06	0.000183	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	6.72e-06	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	6.72e-06	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	6.68e-06	0.00018	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.68e-06	0.00018	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.65e-06	0.000179	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.61e-06	0.000178	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	6.58e-06	0.000177	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	6.52e-06	0.000176	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—Alzheimer's disease	6.49e-06	0.000175	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	6.47e-06	0.000174	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	6.24e-06	0.000168	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.14e-06	0.000166	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.11e-06	0.000165	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPL—Alzheimer's disease	6.08e-06	0.000164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	5.99e-06	0.000162	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPL—Alzheimer's disease	5.93e-06	0.00016	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	5.86e-06	0.000158	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.59e-06	0.000151	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.47e-06	0.000148	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—Alzheimer's disease	5.34e-06	0.000144	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.14e-06	0.000139	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CALM1—Alzheimer's disease	5.11e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—Alzheimer's disease	5.1e-06	0.000137	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	5.09e-06	0.000137	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	5.05e-06	0.000136	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAV1—Alzheimer's disease	5.05e-06	0.000136	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.03e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.02e-06	0.000136	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.99e-06	0.000135	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	4.98e-06	0.000134	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—Alzheimer's disease	4.97e-06	0.000134	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	4.94e-06	0.000133	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.93e-06	0.000133	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.7e-06	0.000127	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.69e-06	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.68e-06	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.66e-06	0.000126	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.64e-06	0.000125	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	4.57e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.56e-06	0.000123	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.44e-06	0.00012	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INS—Alzheimer's disease	4.35e-06	0.000117	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—Alzheimer's disease	4.33e-06	0.000117	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.32e-06	0.000116	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INS—Alzheimer's disease	4.25e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	4.22e-06	0.000114	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.08e-06	0.00011	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INS—Alzheimer's disease	4e-06	0.000108	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.96e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3.88e-06	0.000105	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.82e-06	0.000103	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.73e-06	0.000101	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.51e-06	9.47e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.49e-06	9.42e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.41e-06	9.19e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.26e-06	8.8e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.21e-06	8.66e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	3.19e-06	8.61e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—Alzheimer's disease	3.13e-06	8.46e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.99e-06	8.06e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.92e-06	7.88e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.75e-06	7.43e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.69e-06	7.27e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.75e-06	4.73e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.71e-06	4.62e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.61e-06	4.35e-05	CbGpPWpGaD
